HK Stock Market Move | BRAINAURORA-B (06681) rose nearly 19% again this morning, rebounding twofold from its low in just 7 trading days; first blockbuster medical device certificate approved

BRAINAURORA-B (06681) rose nearly 19% again this morning, with the company's share price surging on heavy volume for consecutive sessions, soaring over 210% from its low on October 20. As of press time, it was up 8.24% at HK$1.97, with turnover of HK$703 million. On the news front, BrainAurora recently announced that its self-developed cognitive function assessment software for depression has been approved for a Class II medical device registration certificate, becoming China's first "depression cognitive assessment" medical device product registration certificate. This marks a major breakthrough in the field of cognitive assessment for mental illness, and also marks further improvement in BrainAurora's layout of digital therapeutic products for cognitive disorders. In addition, on October 28, southbound funds increased their holdings of BrainAurora by 17.876 million shares, raising the proportion of northbound holdings to 21.38%.